Conditions

This post was originally published on this site Taking Xpovio (selinexor) in combination with the steroid dexamethasone leads to promising responses in heavily treated patients with relapsed or refractory multiple myeloma, a Phase 2 trial shows. The trial’s findings were reported in “Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma,” a study published in the New…

This post was originally published on this site The U.K.’s National Institute for Health and Care Excellence, widely known as NICE, is recommending that Clovis Oncology‘s Rubraca (rucaparib) be available as a maintenance therapy for women with recurrent epithelial ovarian, fallopian tube and peritoneal cancer who responded to platinum-based chemotherapy, regardless of their BRCA status or previous…

This post was originally published on this site The U.S. Food and Drug Administration (FDA) has granted priority review to the application seeking trastuzumab deruxtecan‘s (DS-8201) approval for the treatment of metastatic HER2-positive breast cancer. The agency has set a Prescription Drug User Fee Act action date for the second quarter of 2020. By then,…

This post was originally published on this site Cancer scars our insides and outsides, but it’s hard to know which it affects more. Cancer affects the body, but the impact of treatment — from chemotherapy to radiotherapy to immunotherapy to stem cell transplants — is highly psychological. My body is slowly healing, but the hardest…

This post was originally published on this site Depression and anxiety may worsen the quality of life and lung function of patients with pulmonary sarcoidosis, a study has found. The findings of the study, “Psychological burden associated with worse clinical outcomes in sarcoidosis,” were published in the journal BMJ Open Respiratory Research. Statistics indicate that…

This post was originally published on this site Multiple myeloma patients treated in their community by local oncologists have poorer survival outcomes than those receiving care at centers that see large numbers of patients or are nationally recognized, and likely to have doctors with more experience in this disease, a study reports. Its findings were…

This post was originally published on this site The search for a cure for ovarian cancer has been given a boost by a $5 million gift that will support the clinical research of David S. Alberts, MD, an expert in the field of ovarian cancer research and treatment at the University of Arizona (UA) College…

This post was originally published on this site Radiotherapy plans generated with machine learning in the RayStation system are now being used at the Princess Margaret Cancer Centre, in Canada, to treat men with localized prostate cancer. RayStation is a treatment planning system (TPS) to optimize care for cancer patients. It combines features such as…

This post was originally published on this site AstraZeneca‘s Imfinzi (durvalumab) decreases the spread of cancer to other parts of the body, explaining the enhanced survival in patients with stage 3 inoperable non-small-cell lung cancer (NSCLC), according to a new analysis of Phase 3 data.  This analysis of survival data was gathered from the Phase 3…

This post was originally published on this site A Phase 2 clinical trial assessing Solasia Pharma’s lead candidate darinaparsin as a treatment for relapsed or refractory peripheral T-cell lymphoma (PTCL) in Asian patients has reached its target enrollment, the company announced. The Asian multinational study (NCT02653976) has recruited 67 patients across 24 sites in Japan,…

This post was originally published on this site A newly developed imaging approach that combines laser microscopy with computational analysis may make it easier to spot ovarian cancer cells that have spread to other organs, called metastasis, a study found. The new technique was described in a paper, titled “Two-photon images reveal unique texture features…